Amresco, Inc.
United StatesFDA applicant, unverified
- Devices
- 39
What Amresco, Inc. makes
Amresco, Inc. manufactures diagnostic reagents for clinical chemistry testing, including triglyceride, albumin, creatinine, chloride, bicarbonate, and bilirubin assays. Their portfolio also covers enzyme reagents like alkaline phosphatase and AST, as well as buffer and substrate concentrates for laboratory use.
The company’s products are regulated under FDA’s 510(k) clearance process, with devices classified as Class I (general controls) and Class II (special controls). Reagents are listed in the FDA’s 510(k) registry and comply with U.S. medical device regulations.
Catalogue
Search and filter all 39 devicesFrequently asked questions
How many devices does Amresco, Inc. have in the registry?
The registry currently lists 39 devices for Amresco, Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Amresco, Inc.'s devices?
Among its 39 most recently registered devices, Amresco, Inc. has devices listed in FDA 510(k) (39 devices).
What risk classes do Amresco, Inc.'s devices fall under?
Among its 39 most recently registered devices, the classes recorded for Amresco, Inc.'s devices are Class I and Class II. Each device page shows its own class and authorisation.
What are the newest devices from Amresco, Inc. in the registry?
The most recently registered devices listed for Amresco, Inc. include FLOW-PAC TRIGLYCERIDE REAGENT, BICARBONATE REAGENTS AMRESCO PRODUCT #4326020, LIQUILYME BUN REAGENT and AMRESCO SUBST CONCEN, PRO #2432, BUF, NAD, 2455, TRI.